☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Countries
US vs EU P/E
IPO Tracker
Insider Buying
CEO Changes
M&A Tracker
Short Selling
Fear & Greed
AI Models
Macro
▾
EU Economy
US Economy
EU Jobs & Unemployment
US Jobs & Unemployment
EU Housing
US Housing
EU Government Debt
US Federal Debt
ECB Rates & Inflation
Fed Rates & Inflation
EU Yield Curve
US Yield Curve
Health
▾
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
More
▾
Denmark
Danish Tax
Tesla
EU XBRL Tables
Contact
Obesity
Blog
US
2 posts
Diabetes and the third quarter of 2019
2 November 2019
·
Diabetes
Eli Lilly
Europe
Novo Nordisk and Eli Lilly have both reported their Q3 results. Below are some of the headlines related to their diabetes business.
Diabetes developments in the first quarter of 2019
3 May 2019
·
2019Q1
Diabetes
GLP1